Table 2 Sample characteristics for single-nuclei sequencing. The table shows clinical characteristics and quality metrics for the single-nuclei cohort. Clinical characteristics include site of biopsy, tumor entity, and inflammation group. Quality metrics are the number of nuclei per sample, the median UMI counts per nucleus, and the median number of transcripts per nucleus. (ACC=Adenoid Cystic Carcinoma, AdC=Adenocarcinoma, BCC=Basal Cell Carcinoma, CS=Carcinosarcoma, CEPA=Carcinoma ex Pleomorphic Adenoma, MEC=Mucoepidermoid Carcinoma, SDC=Salivary Duct Carcinoma)
Sample | Site Biopsy | Entity | # nuclei | Immune cluster | median UMI counts/nucleus | median transcripts/nucleus |
|---|---|---|---|---|---|---|
P-6 | lung | CS | 6640 | High | 4254 | 2235 |
P-14 | lung | AdC | 2774 | High | 1740 | 1108 |
P-18 | lymph node | SDC | 4344 | High | 5624 | 2277 |
P-31_1 | primary | CEPA | 3957 | NA | 5034 | 2427 |
P-31_2 | primary | CEPA | 3839 | NA | 4824 | 2395 |
P-32 | primary | ACC | 4667 | Low | 2495 | 1545 |
P-33 | skin | ACC | 5455 | Low | 3867 | 2064 |
P-42 | lung | ACC | 10273 | High | 3750 | 1892 |
P-46_1 | lung | BCC | 8082 | Low | 7149 | 2834 |
P-46_2 | lung | BCC | 7864 | Low | 7152 | 2773 |
P-66_1 | lymph node | BCC | 5973 | High | 4756 | 2292 |
P-66_2 | lymph node | BCC | 4664 | High | 3961 | 2049 |
P-74 | primary | MEC | 4802 | Medium | 2179 | 1358 |
P-79 | skin | AdC | 2861 | Medium | 3261 | 1811 |
P-85 | lung | ACC | 6497 | High | 2920 | 1804 |
P-103 | lung | ACC | 4343 | Medium | 4095 | 2277 |
